{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:39:14Z","timestamp":1791171554668,"version":"4.1.0"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,4,3]],"date-time":"2006-04-03T00:00:00Z","timestamp":1144022400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Benzoyl peroxide (BPO) was introduced in the treatment of acne in 1934. Despite the fact that only few randomized trials have been published, BPO is considered the standard in topical acne treatment. Anaerobic bacteria are reduced by oxidative mechanisms and the induction of resistant strains is reduced. Topical formulations are available at concentrations of 2.5, 5, 10 and 20 %. The effect is dose\u2010dependent, but the irritation increases with higher concentrations. Usually 5 % BPO is sufficient to control acne grade I\u2010II. Due to its strong oxidative potential, patients should be advised that BPO may bleach colored and dark clothing, bedding and even hair. BPO is safe for use in pregnant and lactating females because it is degraded to benzoic acid. It is a cost\u2010effective treatment for acne grade I\u2013II.<\/jats:p><jats:p>Patients with papulopustular acne grade I\u2013II, particularly with marked inflammation, show satisfactory improvement with topical antibiotic treatment. The following compounds are available and effective: erythromycin, clindamycin and tetracycline (the latter being less frequently used). A review in 1990 suggested that topical tetracycline was ineffective in the treatment of acne. Along with eliminating <jats:italic>Propionibacterium acnes<\/jats:italic>, the main mechanism of topical antibiotics is their antiinflammatory effect. All three penetrate the epidermal barrier well and are similarly efficacious. Randomized trials have shown that in concentrations of 2\u20134 %, their effects are comparable to oral tetracycline and minocycline. Combination therapy with retinoids or benzoyl peroxide (BPO) increases efficacy. Retinoids increase penetration and reduce comedones, while topical antibiotics primarily address inflammation. One side effect of topical antibacterial treatment is an increase in drug\u2010resistant resident skin flora with gram\u2010negative microorganisms prevailing, which can lead to gram\u2010negative folliculitis. All three antibiotics fluoresce under black light which may produce interesting effects in a discotheque. There are two reports of topical clindamycin causing pseudomembranous colitis after long\u2010term and widespread usage.<\/jats:p><jats:p>Azelaic acid has a predominant antibacterial action, although it is not considered as an antibiotic in the classical sense. Furthermore, it possesses a modest comedolytic effect. Burning upon application is common. Since azelaic acid is naturally present, systemic side effects are not likely to occur, making it safe for acne treatment during pregnancy and lactation.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2006.05931.x","type":"journal-article","created":{"date-parts":[[2006,4,3]],"date-time":"2006-04-03T08:56:38Z","timestamp":1144054598000},"page":"293-300","source":"Crossref","is-referenced-by-count":61,"title":["Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid"],"prefix":"10.1111","volume":"4","author":[{"given":"Wolf\u2010Ingo","family":"Worret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim W.","family":"Fluhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,3]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb13101.x"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000056395"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(83)70211-2"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249352"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70177-4"},{"key":"e_1_2_9_7_2","first-page":"90","article-title":"Benzoyl peroxide lotion (20 percent) in acne","volume":"25","author":"Smith EB","year":"1980","journal-title":"Cutis"},{"key":"e_1_2_9_8_2","first-page":"169","volume-title":"How to practice and teach EBM","author":"Sackett DL","year":"2001"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1986.tb04534.x"},{"key":"e_1_2_9_10_2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2340\/0001555562458459","article-title":"Benzoyl peroxide: lack of sensitization","volume":"62","author":"Cunliffe WJ","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249739"},{"key":"e_1_2_9_12_2","first-page":"873","article-title":"[Miconazole\u2010benzoyl peroxide: a new combination for extending the topical therapy of acne]","volume":"59","author":"Fanta D","year":"1984","journal-title":"Z Hautkr"},{"key":"e_1_2_9_13_2","first-page":"370","article-title":"Local treatment of acne. A clinical study and evaluation of the effect of different concentrations of benzoyl peroxide gel","volume":"7","author":"Lassus A","year":"1981","journal-title":"Curr Med Res Opin"},{"key":"e_1_2_9_14_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archderm.1981.01650090033020","article-title":"Topical erythromycin vs blank vehicle in a multiclinic acne study","volume":"117","author":"Jones EL","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_15_2","first-page":"151","article-title":"Nueva sal de eritromicina (A\u2010137 o laurilsulfato de eritromicina) en el tratamiento topico del acne","volume":"10","author":"Perez Lopez M","year":"1982","journal-title":"Med Cutan Ibero Lat Am"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808101500506"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.123483"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017846"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304120-00002"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05067.x"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04690.x"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(99)80123-6"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017871"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb15518.x"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(99)80084-X"},{"key":"e_1_2_9_26_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1742-1241.1981.tb08234.x","article-title":"The effect of a topical antibiotic preparation in acne vulgaris \u2013 a controlled clinical and laboratory study","volume":"35","author":"Saihan EM","year":"1981","journal-title":"Br J Clin Pract"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007998009109468"},{"key":"e_1_2_9_28_2","first-page":"188","article-title":"Antibacterial and sebosuppressive efficacy of a combination of chloramphenicol and pale sulfonated shale oil. Multicentre, randomized, vehicle\u2010controlled, double\u2010blind study on 91 acne patients with acne papulopustulosa (Plewig and Kligman's grade II\u2010III)","volume":"48","author":"Fluhr JW","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_9_29_2","first-page":"952","article-title":"Chloramphenicol and benzoyl peroxide in acne. A double\u2010blind clinical study","volume":"224","author":"Cunliffe WJ","year":"1980","journal-title":"Practitioner"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1108220"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1989.tb04730.x"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050701"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70252-W"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01962381"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199500492-00065"},{"key":"e_1_2_9_36_2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archderm.1981.01650080036024","article-title":"Topical clindamycin therapy for acne vulgaris. A cooperative clinical study","volume":"117","author":"Becker LE","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_37_2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archderm.1975.01630200057005","article-title":"Clindamycin vs placebo as adjunctive therapy in moderately severe acne","volume":"111","author":"Christian GL","year":"1975","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102010-00006"},{"key":"e_1_2_9_39_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archderm.1981.01650030032015","article-title":"Pseudomembranous colitis after topical application of clindamycin","volume":"117","author":"Milstone EB","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.122.5.583"},{"key":"e_1_2_9_41_2","first-page":"165","article-title":"A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris","volume":"67","author":"Tschen EH","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197606000-00007"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12481914"},{"key":"e_1_2_9_44_2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/archderm.1976.01630310033006","article-title":"Topical use of tetracycline in the treatment of acne: a double\u2010blind study comparing topical and oral tetracycline therapy and placebo","volume":"112","author":"Blaney DJ","year":"1976","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_45_2","first-page":"109","article-title":"Acne treatment: a comparative efficacy trial of clindamycin and tetracycline","volume":"19","author":"Panzer JD","year":"1977","journal-title":"Cutis"},{"key":"e_1_2_9_46_2","volume-title":"Akne","author":"Cunliffe WJ","year":"1993"},{"key":"e_1_2_9_47_2","first-page":"471","article-title":"[National and international clinical experiences with azelaic acid cream in the treatment of comedo acne]","volume":"124","author":"Giannotti B","year":"1989","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_9_48_2","first-page":"20","article-title":"Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reports","volume":"57","author":"Graupe K","year":"1996","journal-title":"Cutis"},{"key":"e_1_2_9_49_2","first-page":"538","article-title":"Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne","volume":"11","author":"Gollnick HP","year":"2001","journal-title":"Eur J Dermatol"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2004.04731.x"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2006.05931.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2006.05931.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:02:47Z","timestamp":1696982567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2006.05931.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1111\/j.1610-0387.2006.05931.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2006.05931.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}